215 related articles for article (PubMed ID: 11154954)
1. In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging.
Viehweg P; Lampe D; Buchmann J; Heywang-Köbrunner SH
MAGMA; 2000 Dec; 11(3):129-37. PubMed ID: 11154954
[TBL] [Abstract][Full Text] [Related]
2. MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?
Hahn SY; Han BK; Ko EY; Shin JH; Hwang JY; Nam M
Acta Radiol; 2013 Sep; 54(7):742-8. PubMed ID: 23588154
[TBL] [Abstract][Full Text] [Related]
3. Ductal carcinoma in situ: is there a role for MRI?
Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
[TBL] [Abstract][Full Text] [Related]
4. [Ductal carcinoma in situ in dynamic MR-mammography at 1.5 T].
Fischer U; Westerhof JP; Brinck U; Korabiowska M; Schauer A; Grabbe E
Rofo; 1996 Apr; 164(4):290-4. PubMed ID: 8645861
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ.
Soderstrom CE; Harms SE; Copit DS; Evans WP; Savino DA; Krakos PA; Farrell RS; Flamig DP
Radiology; 1996 Nov; 201(2):427-32. PubMed ID: 8888235
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of ductal carcinoma in situ in magnetic resonance imaging.
Facius M; Renz DM; Neubauer H; Böttcher J; Gajda M; Camara O; Kaiser WA
Clin Imaging; 2007; 31(6):394-400. PubMed ID: 17996602
[TBL] [Abstract][Full Text] [Related]
7. [Morphology and contrast enhancement of ductal carcinoma in situ in dynamic 1.0 T MR mammography].
Sittek H; Kessler M; Heuck AF; Bredl T; Perlet C; Künzer I; Lebeau A; Untch M; Reiser M
Rofo; 1997 Sep; 167(3):247-51. PubMed ID: 9376552
[TBL] [Abstract][Full Text] [Related]
8. Ductal carcinoma in situ of the breast: MR imaging findings with histopathologic correlation.
Mossa-Basha M; Fundaro GM; Shah BA; Ali S; Pantelic MV
Radiographics; 2010 Oct; 30(6):1673-87. PubMed ID: 21071382
[TBL] [Abstract][Full Text] [Related]
9. Comparison of MRI features of different grades of DCIS and invasive carcinoma of the breast.
Van Goethem M; Schelfout K; Kersschot E; Colpaert C; Weyler J; Verslegers I; Biltjes I; De Schepper A; Parizel PM
JBR-BTR; 2005; 88(5):225-32. PubMed ID: 16302331
[TBL] [Abstract][Full Text] [Related]
10. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
[TBL] [Abstract][Full Text] [Related]
11. Ductal carcinoma in situ: MR imaging-histopathologic correlation.
Gilles R; Zafrani B; Guinebretière JM; Meunier M; Lucidarme O; Tardivon AA; Rochard F; Vanel D; Neuenschwander S; Arriagada R
Radiology; 1995 Aug; 196(2):415-9. PubMed ID: 7617854
[TBL] [Abstract][Full Text] [Related]
12. MR imaging of ductal carcinoma in situ.
Orel SG; Mendonca MH; Reynolds C; Schnall MD; Solin LJ; Sullivan DC
Radiology; 1997 Feb; 202(2):413-20. PubMed ID: 9015067
[TBL] [Abstract][Full Text] [Related]
13. Kinetic characteristics of ductal carcinoma in situ (DCIS) in dynamic breast MRI using computer-assisted analysis.
Vag T; Baltzer PA; Dietzel M; Benndorf M; Gajda M; Camara O; Kaiser WA
Acta Radiol; 2010 Nov; 51(9):955-61. PubMed ID: 20942728
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography.
Oshida K; Nagashima T; Ueda T; Yagata H; Tanabe N; Nakano S; Nikaidou T; Funatsu H; Hashimoto H; Miyazaki M
Eur Radiol; 2005 Jul; 15(7):1353-60. PubMed ID: 15789211
[TBL] [Abstract][Full Text] [Related]
15. Three-phase dynamic breast magnetic resonance imaging with two-way subtraction.
Choi N; Han BK; Choe YH; Kim HS
J Comput Assist Tomogr; 2005; 29(6):834-41. PubMed ID: 16272861
[TBL] [Abstract][Full Text] [Related]
16. Is there different correlation with prognostic factors between "non-mass" and "mass" type invasive ductal breast cancers?
Jiang L; Zhou Y; Wang Z; Lu X; Chen M; Zhou C
Eur J Radiol; 2013 Sep; 82(9):1404-9. PubMed ID: 23540946
[TBL] [Abstract][Full Text] [Related]
17. MRI of the breast for the detection and assessment of the size of ductal carcinoma in situ.
Kim DY; Moon WK; Cho N; Ko ES; Yang SK; Park JS; Kim SM; Park IA; Cha JH; Lee EH
Korean J Radiol; 2007; 8(1):32-9. PubMed ID: 17277561
[TBL] [Abstract][Full Text] [Related]
18. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.
Stomper PC; Herman S; Klippenstein DL; Winston JS; Edge SB; Arredondo MA; Mazurchuk RV; Blumenson LE
Radiology; 1995 Nov; 197(2):387-95. PubMed ID: 7480682
[TBL] [Abstract][Full Text] [Related]
19. Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ vs. invasive ductal carcinoma.
Nadrljanski M; Maksimović R; Plešinac-Karapandžić V; Nikitović M; Marković-Vasiljković B; Milošević Z
Eur J Radiol; 2014 Aug; 83(8):1363-7. PubMed ID: 24894697
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced MRI of ductal carcinoma in situ: characteristics of a new intensity-modulated parametric mapping technique correlated with histopathologic findings.
Mariano MN; van den Bosch MA; Daniel BL; Nowels KW; Birdwell RL; Fong KJ; Desmond PS; Plevritis S; Stables LA; Zakhour M; Herfkens RJ; Ikeda DM
J Magn Reson Imaging; 2005 Oct; 22(4):520-6. PubMed ID: 16142701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
